Tag: Radiopharmaceuticals and chemical probes

New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals

September 14, 2022

OICR joins European consortium to ‘enable and unlock biology in the open’

June 16, 2020

Ontario centre attracts national attention for probe research, development and commercialization

August 2, 2018

FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A

October 4, 2017

How chemical probes can boost cancer research

February 10, 2017

FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic

March 16, 2016

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics

December 16, 2015